2026 NPPES data Neurology Physician NPI 1629204383 M.D.
Verify on CMS →

MATTHEW MEYER, M.D.

Neurology Physician in SEYMOUR, Indiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 437 beneficiaries · Neurology Physician avg: 1K
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
90.141/100
▲ 7 pts above national avg 83.1 · [object Object]
Industry payments
$754.57
42 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MATTHEW MEYER, M.D. is a Neurology Physician ([object Object]) practicing in SEYMOUR, Indiana with a Medicare Part D prescribing footprint of 3K claims across 437 beneficiaries — 13% brand-name prescribing . Their CMS MIPS Final Score of 90.141/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $754.57 across 42 transactions are disclosed under CMS Open Payments (Sunshine Act).

What the federal data shows

MATTHEW MEYER, M.D. reported a CMS MIPS final score of 90.141/100 — above the 83.1 national average — and filed 2,577 Medicare Part D claims in 2023.

90.141/100
MIPS score · +7 vs avg
3K
Part D claims, 2023
87%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MATTHEW MEYER, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

90 Top 40% higher than 60% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MATTHEW MEYER, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MATTHEW MEYER, M.D. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 06/08/2009

NPI 1629204383

Primary specialty

Neurology Physician

Mid-sized

19,866 US NPIs in this specialty

Medicare Part D claims

2,577 97% vs specialty avg

2023 prescription claims

Specialty avg: 1,309

MIPS final score

90.141/100 7.041000000000011% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Indiana

How Neurology Physician compares to other specialties among Indiana providers

Indiana providers

Neurology Physician share within Indiana

1. Neurology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Neurology Physician share within Indiana

Medicare quality performance — MIPS

MATTHEW MEYER, M.D.'s 2023 MIPS final score plotted against the Neurology Physician national average

High performer (top quartile)
MIPS Final Score
90.141/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Neurology Physician) — 90.141/100 vs national avg 83.1

0%100%National avg83%90.1%
MIPS final score (Neurology Physician) — 90.141/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MATTHEW MEYER, M.D. is a Neurology Physician provider practicing in SEYMOUR, Indiana, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1629204383. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MATTHEW MEYER, M.D. appears in the CMS NPPES registry as a Neurology Physician provider holding M.D. credentials at 225 S PINE ST, SEYMOUR, IN, 47274, with a listed phone of (812) 523-7893. NPI 1629204383 was issued on 06/08/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MEYER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,577 prescription claims written by this provider, covering 437 Medicare beneficiaries and totaling roughly $1.2 million in drug spend, split 13% brand-name and 87% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 90.141/100 for the 2023 performance year (Quality 81.1402), compared with the national average of 83.1.

Neurology Physician is a mid-sized specialty nationwide, with 19,866 enrolled providers across 54 states and an average of 1,309 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

225 S PINE ST
SEYMOUR, IN 47274

Provider Details

NPI 1629204383
Specialty Neurology Physician
Credentials M.D.
Gender Male
NPI Issued 06/08/2009

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

90.141
Final Score
Avg: 83.1
81.1402
Quality
93.3007
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where MATTHEW MEYER, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

JACKSON COUNTY SCHNECK MEMORIAL HOSPITAL
SCOTTSBURG, IN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MATTHEW MEYER, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$755

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

MATTHEW MEYER, M.D. — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 2,577 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,577
Total Claims
$1.2M
Total Drug Cost
437
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,826
Total Day Supply
108,149
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$982K
Generic Drug Cost
$230K

Patient Demographics

Average Patient Age
67.2 years
Avg HCC Risk Score
1.51
Gender Split
58% female / 42% male
Age Distribution
<65: 151, 65-74: 147, 75-84: 105, 85+: 34

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levetiracetam
244
Donepezil Hcl
163
Gabapentin
119
Memantine Hcl
118
Topiramate
117
Carbidopa-Levodopa
Carbidopa/Levodopa
91
Duloxetine Hcl
88
Baclofen
85
Ropinirole Hcl
84
Pregabalin
81

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neurology Physician Overview

How MATTHEW MEYER, M.D. fits within the Neurology Physician landscape nationally.

19,866
Neurology Physician Providers in US
54
States with Neurology Physician
1,309
Avg Claims per Provider

MATTHEW MEYER, M.D.'s 2,577 claims are above the specialty average of 1,309.

Nearby Neurology Physician Providers in Indiana

Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as MEYER.

Compare Neurology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MATTHEW MEYER, M.D.'s specialty?
MATTHEW MEYER, M.D. specializes in Neurology Physician and practices in SEYMOUR, Indiana. Credentials: M.D..
How much does MATTHEW MEYER, M.D. prescribe under Medicare Part D?
In 2023, MATTHEW MEYER, M.D. wrote 2,577 Medicare Part D claims totaling $1.2M in drug costs for 437 beneficiaries.
What is MATTHEW MEYER, M.D.'s Medicare quality score?
MATTHEW MEYER, M.D. has a CMS MIPS Final Score of 90.141/100 (Quality: 81.1402). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MATTHEW MEYER, M.D. located?
MATTHEW MEYER, M.D. is located at 225 S PINE ST, SEYMOUR, IN, 47274. Phone: (812) 523-7893.
What is MATTHEW MEYER, M.D.'s NPI number?
MATTHEW MEYER, M.D.'s National Provider Identifier (NPI) is 1629204383, issued on 06/08/2009.
Does MATTHEW MEYER, M.D. prescribe more brand-name or generic drugs?
MATTHEW MEYER, M.D.'s prescribing is 13% brand-name and 87% generic drugs by claim count, with $982K in brand drug costs.
How many Neurology Physician providers are there in the US?
There are 19,866 Neurology Physician providers across 54 states in the US. The average Neurology Physician provider writes 1,309 Medicare Part D claims per year.
What drugs does MATTHEW MEYER, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MATTHEW MEYER, M.D.'s most frequently prescribed drugs include Levetiracetam, Donepezil Hcl, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MATTHEW MEYER, M.D. accept Medicare?
MATTHEW MEYER, M.D. appears in CMS Medicare data with 2,577 Part D claims and 437 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MATTHEW MEYER, M.D.'s credentials?
MATTHEW MEYER, M.D.'s NPI is 1629204383 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology